A workshop on the implementation of NAT to screen donors of blood and plasma for viruses, sponsored by the FDA, was held on December 14, 1999, in Bethesda, MD. Participants included representatives from companies that are testing donations of blood and plasma under investigational new drug exemptions (INDs), representatives of blood and plasma trade organizations, foreign regulatory and public health officials, and FDA staff members. The goal of the workshop was to discuss the issues and progress in implementing NAT to detect viruses in blood and plasma, including HCV, HIV‐1, HBV, and parvovirus B19. An earlier workshop, in 1998, had addressed many aspects of NAT screening for HCV. At the present workshop, industry representatives reported a projection that >99 percent of whole blood and source plasma collected in the United States would be tested in minipools by NAT for both HCV and HIV‐1 by the end of 1999. In actuality, 99 percent of source plasma and >95 percent of whole blood were being tested by NAT for both HCV and HIV‐1 by the end of 1999. In the United States at the present time, pool sizes for NAT screening of source plasma range from 96 to 1200 units
Transfusion – Wiley
Published: Jan 1, 2000
Keywords: ; ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera